Robert Levin

682 total citations
14 papers, 285 citations indexed

About

Robert Levin is a scholar working on Pharmacology, Dermatology and Toxicology. According to data from OpenAlex, Robert Levin has authored 14 papers receiving a total of 285 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Pharmacology, 3 papers in Dermatology and 3 papers in Toxicology. Recurrent topics in Robert Levin's work include Pharmacovigilance and Adverse Drug Reactions (3 papers), Drug-Induced Adverse Reactions (2 papers) and Computational Drug Discovery Methods (2 papers). Robert Levin is often cited by papers focused on Pharmacovigilance and Adverse Drug Reactions (3 papers), Drug-Induced Adverse Reactions (2 papers) and Computational Drug Discovery Methods (2 papers). Robert Levin collaborates with scholars based in United States, Thailand and Canada. Robert Levin's co-authors include Thomas Laughren, Cindy Kortepeter, Baruch D. Jakubovic, Zhao‐Hua Zhou, Steven Kozlowski, Jana McAninch, Mónica Muñoz, Mark Avigan, Eileen Wu and David G. Strauss and has published in prestigious journals such as The Journal of Pediatrics, Schizophrenia Bulletin and Clinical Pharmacology & Therapeutics.

In The Last Decade

Robert Levin

13 papers receiving 272 citations

Peers

Countries citing papers authored by Robert Levin

Since Specialization

Citations

This map shows the geographic impact of Robert Levin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert Levin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert Levin more than expected).

Fields of papers citing papers by Robert Levin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert Levin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert Levin. The network helps show where Robert Levin may publish in the future.

Co-authorship network of co-authors of Robert Levin

This figure shows the co-authorship network connecting the top 25 collaborators of Robert Levin. A scholar is included among the top collaborators of Robert Levin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert Levin. Robert Levin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

#	Work	Indexed citations
1	Anti-PEG IgE in anaphylaxis associated with polyethylene glycol 2020 ·The Journal of Allergy and Clinical Immunology In Practice ·Zhao‐Hua Zhou, (unknown), Baruch D. Jakubovic, (unknown), (unknown), (unknown), (unknown), (unknown), Robert Levin, Steven Kozlowski	97
2	Target Adverse Event Profiles for Predictive Safety in the Postmarket Setting 2020 ·Clinical Pharmacology & Therapeutics ·(unknown), Rebecca Racz, David Jackson, Theodoros Soldatos, Robert Levin, David G. Strauss, Keith Burkhart	15
3	Target‐Adverse Event Profiles to Augment Pharmacovigilance: A Pilot Study With Six New Molecular Entities 2018 ·CPT Pharmacometrics & Systems Pharmacology ·(unknown), Rebecca Racz, David Jackson, Robert Levin, David G. Strauss, Keith Burkhart	17
4	Liver injury associated with dimethyl fumarate in multiple sclerosis patients 2017 ·Multiple Sclerosis Journal ·Mónica Muñoz, (unknown), Cindy Kortepeter, Robert Levin, Mark Avigan	28
5	Adverse event detection using the FDA post-marketing drug safety surveillance system: Cardiotoxicity associated with loperamide abuse and misuse 2017 ·Journal of the American Pharmacists Association ·(unknown), Eileen Wu, Cindy Kortepeter, Jana McAninch, Robert Levin	32
6	Acute Generalized Exanthematous Pustulosis in Association with Hydroxyzine and Cetirizine 2017 ·SKIN The Journal of Cutaneous Medicine ·(unknown), Lois La Grenade, (unknown), Robert Levin	0
7	Chemical Leukoderma Associated with Methylphenidate Transdermal System: Data From the US Food and Drug Administration Adverse Event Reporting System 2016 ·The Journal of Pediatrics ·(unknown), Lois La Grenade, (unknown), Allen Brinker, Robert Levin	6
8	Food and Drug Administration Perspective on Negative Symptoms in Schizophrenia as a Target for a Drug Treatment Claim 2005 ·Schizophrenia Bulletin ·Thomas Laughren, Robert Levin	60
9	Depression in the elderly 1997 ·International Clinical Psychopharmacology ·Trey Sunderland, Robert Lasser, Robert Levin, Ruth Dukoff	1
10	Panic disorder in the medical setting 1992 ·General Hospital Psychiatry ·Robert Levin	6
11	Anxiety and depressive disorders in the medical patient 1989 ·General Hospital Psychiatry ·Robert Levin	11
12	Computer‐Assisted Writing 1984 ·New Directions for Community Colleges ·Robert Levin	2
13	The Microcomputer in the Writing/Reading/Study Lab 1983 ·Robert Levin, (unknown)	2
14	Modification of teaching behavior through the combined use of microteaching techniques with the technion diagnostic system TDS 1974 ·Instructional Science ·(unknown), (unknown), Robert Levin, (unknown), (unknown), (unknown)	8

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact